Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-05 Sale | 2025-12-05 6:44 pm | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 2,106 | $14.23 | $29,968 | 30,620 (Direct) | View |
| 2024-12-06 Sale | 2024-12-10 5:12 pm | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 2,283 | $8.06 | $18,401 | 29,305 (Direct) | View |
| 2024-06-17 Sale | 2024-06-17 8:38 pm | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 7,266 | $12.33 | $89,590 | 32,341 (Direct) | View |
| 2023-12-05 Sale | 2023-12-06 8:29 pm | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev | 2,125 | $9.63 | $20,464 | 37,260 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-12 Tax Withholding | 2026-02-13 4:29 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 3,257 | $14.25 | 33,925 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-13 4:29 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 6,562 | $0 | 33,925 (Direct) | View |
| 2025-12-01 Tax Withholding | 2025-12-03 4:37 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 753 | $14.12 | 32,726 (Direct) | View |
| 2025-11-25 Option Award | 2025-11-26 5:11 pm | N/A 2035-11-25 | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-02-12 Tax Withholding | 2025-02-14 4:44 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 3,326 | $5.59 | 33,479 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:44 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 7,500 | $0 | 33,479 (Direct) | View |
| 2024-12-01 Tax Withholding | 2024-12-03 6:37 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 753 | $8.6 | 31,588 (Direct) | View |
| 2024-11-27 Option Award | 2024-11-27 5:06 pm | N/A 2034-11-27 | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 81,000 | $0 | 81,000 (Direct) | View |
| 2024-02-12 Tax Withholding | 2024-02-14 8:21 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 973 | $12.41 | 39,607 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:21 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 3,320 | $0 | 39,607 (Direct) | View |
| 2023-12-01 Tax Withholding | 2023-12-05 9:21 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev | 753 | $9.49 | 39,385 (Direct) | View |
| 2023-11-22 Option Award | 2023-11-22 5:12 pm | N/A 2033-11-22 | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev | 83,000 | $0 | 83,000 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-15 9:51 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. | 6,725 | $52.77 | 40,138 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 9:51 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. | 20,997 | $0 | 40,138 (Direct) | View |
| 2022-12-01 Tax Withholding | 2022-12-05 7:27 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. | 498 | $44.33 | 25,866 (Direct) | View |
| 2022-11-23 Option Award | 2022-11-28 6:38 pm | N/A 2032-11-23 | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. | 58,500 | $0 | 66,364 (Direct) | View |
| 2022-02-14 Tax Withholding | 2022-02-15 9:51 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. | 552 | $62.49 | 7,864 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-15 9:51 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. | 1,616 | $0 | 7,864 (Direct) | View |
| 2021-11-19 Option Award | 2021-11-23 8:00 pm | N/A 2031-11-19 | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. | 35,200 | $0 | 35,200 (Direct) | View |